Welcome to the Radboudumc what are you looking for?
Professor of Clinical Pharmacy David Burger, affiliated with the Radboudumc Pharmacy, is in the list of top scientists in the field of anti-HIV medication.
On Friday 29 October 2021, during the 18th European AIDS Conference in London, the Hector Research Award for the best scientific article related to clinical or epidemiological HIV research was presented to Angela Colbers and David Burger, both working in the Pharmacy of the RadboudUMC.
Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020.
In the International Journal of Clinical Pharmacy Charlotte Bekker showed that patients often face unmet medication information needs and that the quality of the provided information, including accessibility, comprehensiveness, reliability and understandability, is perceived as insufficient.
For children living with HIV, an adapted, simpler combination therapy is now available. Thanks to research by the Radboudumc, it is now clear that the use of one easily available tablet of dolutegravir in children gives just as good treatment results as a combination of several.
With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.
In Lancet HIV RIHS researchers Angela Colbers and David Burger showed in an open-label, randomized controlled trial, that, when initiated in the 3rd trimester of pregnancy, achievement of VL <50cp/mL at delivery was more likely with dolutegravir-based therapy than with efavirenz-based regimens.
Bart van den Bemt will pay particular attention to shared decision-making, improved treatment adherence, effective pharmacotherapy and sustainable drug use.
In Clinical infectious diseases RIHS researchers Pauline Bollen, Jolien Freriksen, Angela Colbers and David Burger together with researchers of the PANNA network showed that dolutegravir use in pregnancy results in effective plasma concentrations.
Peter de Smet, Harry Surayapranata and Stans Verhagen received royal honours for their exceptional academic and social achievements.
Renal or hepatic impairment is a common comorbidity for patients with cancer either because of the disease itself, toxicity of previous anticancer treatments, or because of other factors affecting organ function, such as increased age.
In Clinical Infectious Diseases Angela Colbers, Stein Schalkwijk and David Burger give considerations on how to effectively evaluate aspects of clinical pharmacology required for safe and effective treatment to optimize pharmacotherapy during pregnancy and breastfeeding.
Roger, who subscribed for the national pilot academy in 1992, eventually became a hospital pharmacist and associate professor of clinical pharmacology. This summer he became a “Cinglé du Ventoux”.
On 17 September, David Burger, professor of clinical pharmacy, together with colleagues from the United Kingdom, Uganda and Zimbabwe, received the "Outstanding Research Team" award from the European - Developing Countries Clinical Trial Partnership (EDCTP).
It is our pleasure to announce that Nielka van Erp and Roger Brüggemann have been appointed as associated professor.
Stein Schalkwijk, Angela Colbers and David Burger (Pharmacy) developed the Toolkit in cooperation with Mark Mirochnick (Boston University) as a part of “Toolkit for research and development of paediatric antiretroviral drugs and formulations”.
In Clinical Infectious Diseases Elin Svensson and colleagues showed that increasing rifampicin exposure shortened the time needed to reach undetectable levels of bacteria in sputum.
In Clinical Pharmacokinetics David Burger, Ruben van der Galiën and colleagues discuss that although yearly over a million of women with HIV get pregnant, it is often still unknown whether treatment with HIV-integrase inhibitors results in adequate drug exposure.
In Clinical Pharmacokinetics Stein Schalkwijk and colleagues described the feasibility to reduce the efavirenz dose in HIV-positive pregnant women to minimize treatment costs and limit toxicity.
Pauline received this award for the best abstract of original research on HIV-infected patients. Lecture title: The pharmacokinetics and safety of dolutegravir in HIV-infected pregnant women.
Chair of the RIHS PhD council and PhD candidate at the department of Pharmacy, with focus on Pharmacokinetics of antifungals in morbidly obese adults.
Kramers' teaching and research focuses on medication safety in the hospital setting. Medication errors are one of the biggest risks for hospitalised patients.
This website uses cookies. Read more about cookies.